Crysalo
Pain Relieving Spray
Crysalo should be administered under the supervision of a licensed medical practitioner.
The following Structured Product Label (SPL) was submitted to the FDA by V2 Pharma, Llc for the product Crysalo (NDC 72835-511). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding crysalo, methyl salicylate 11%, menthol 5%, topical analgesic, uses, directionsadults and children 12 years of age and older:, fore external use only. avoid contact with the eyes.keep out of reach of children., stop use and ask doctor if:, if swallowed, get medical help or contact a poison control center immediately., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Pain Relieving Spray
Crysalo should be administered under the supervision of a licensed medical practitioner.
Temporary relief of minor aches and pains associated with:
Apply to affected area not more then 3 to 4 times daily.
No need to rub in.
For children under 12 years of age: Ask a doctor.
When using this product
Do not apply to wounds or damaged skin. Do not bandage tightly. Do not use with heating pad. Rinse with soap and water to remove. Wash hands with soap and water after use.
Condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use of this product and consult a physician.
* Please review the disclaimer below.